KEGG   COMPOUND: C00062Help
Entry
C00062                      Compound                               

Name
L-Arginine;
(S)-2-Amino-5-guanidinovaleric acid;
L-Arg
Formula
C6H14N4O2
Exact mass
174.1117
Mol weight
174.201
Structure
Mol fileKCF fileDB search
Remark
Same as: D02982
Reaction
Pathway
map00220  Arginine biosynthesis
map00261  Monobactam biosynthesis
map00330  Arginine and proline metabolism
map00331  Clavulanic acid biosynthesis
map00472  D-Arginine and D-ornithine metabolism
map00970  Aminoacyl-tRNA biosynthesis
map00999  Biosynthesis of secondary metabolites - unclassified
map01060  Biosynthesis of plant secondary metabolites
map01064  Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01130  Biosynthesis of antibiotics
map01230  Biosynthesis of amino acids
map02010  ABC transporters
map04150  mTOR signaling pathway
map04974  Protein digestion and absorption
map05014  Amyotrophic lateral sclerosis (ALS)
map05132  Salmonella infection
map05142  Chagas disease (American trypanosomiasis)
map05146  Amoebiasis
map05230  Central carbon metabolism in cancer
Module
M00029  Urea cycle
M00047  Creatine pathway
M00133  Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine
M00134  Polyamine biosynthesis, arginine => ornithine => putrescine
M00674  Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate
M00736  Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A
M00785  Cycloserine biosynthesis, arginine/serine => cycloserine
M00844  Arginine biosynthesis, ornithine => arginine
M00845  Arginine biosynthesis, glutamate => acetylcitrulline => arginine
Enzyme
1.4.1.25        1.4.3.25        1.5.1.11        1.5.1.19        
1.13.12.1       1.14.11.41      1.14.13.39      1.14.14.47      
1.14.20.7       2.1.4.1         2.1.4.2         2.3.1.109       
2.5.1.66        2.6.1.84        2.7.3.3         3.2.2.19        
3.5.3.1         3.5.3.6         4.1.1.19        4.3.2.1         
5.1.1.9         6.1.1.19        6.3.2.11        6.3.2.24        
6.3.2.30        6.3.2.48
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00062  Arginine (Arg)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   L-Arginine
    D02982  Arginine (USP/INN)
Pharmaceutical additives in Japan [BR:br08316]
 Stabilizing agent
  D02982  [003610] L-Arginine
 Solubilizing agent
  D02982  [003610] L-Arginine
 Buffering agent
  D02982  [003610] L-Arginine
 Solubilization agent
  D02982  [003610] L-Arginine
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D02982  L-Arginine
BRITE hierarchy
Other DBs
CAS: 74-79-3
PubChem: 3362
ChEBI: 16467
ChEMBL: CHEMBL1485
KNApSAcK: C00001340
PDB-CCD: ARG[PDBj] GND[PDBj]
3DMET: B01143
NIKKAJI: J9.182K
KCF data Show

ATOM        12
            1   C1b C    24.1085  -18.0306
            2   C1b C    25.3110  -18.7488
            3   C1c C    22.8766  -18.7137
            4   C1b C    26.5369  -18.0657
            5   C6a C    21.7324  -17.9664
            6   N1a N    22.9232  -20.1148
            7   N1b N    27.7453  -18.7779
            8   O6a O    20.5065  -18.6494
            9   O6a O    21.6856  -16.5596
            10  C2c C    28.9714  -18.1007
            11  N1a N    30.1739  -18.8129
            12  N2a N    28.9888  -16.6938
BOND        11
            1     1   2 1
            2     1   3 1
            3     2   4 1
            4     3   5 1
            5     3   6 1 #Down
            6     4   7 1
            7     5   8 1
            8     5   9 2
            9     7  10 1
            10   10  11 1
            11   10  12 2

» Japanese version

KEGG   COMPOUND: C00047Help
Entry
C00047                      Compound                               

Name
L-Lysine;
Lysine acid;
2,6-Diaminohexanoic acid
Formula
C6H14N2O2
Exact mass
146.1055
Mol weight
146.1876
Structure
Mol fileKCF fileDB search
Remark
Same as: D02304
Reaction
Pathway
map00300  Lysine biosynthesis
map00310  Lysine degradation
map00780  Biotin metabolism
map00960  Tropane, piperidine and pyridine alkaloid biosynthesis
map00970  Aminoacyl-tRNA biosynthesis
map01060  Biosynthesis of plant secondary metabolites
map01064  Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01120  Microbial metabolism in diverse environments
map01130  Biosynthesis of antibiotics
map01210  2-Oxocarboxylic acid metabolism
map01230  Biosynthesis of amino acids
map02010  ABC transporters
map04974  Protein digestion and absorption
Module
M00016  Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine
M00030  Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine
M00031  Lysine biosynthesis, mediated by LysW, 2-aminoadipate => lysine
M00032  Lysine degradation, lysine => saccharopine => acetoacetyl-CoA
M00525  Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine
M00526  Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine
M00527  Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine
Enzyme
1.4.1.15        1.4.1.18        1.4.3.14        1.4.3.20        
1.5.1.7         1.5.1.8         1.5.1.16        1.5.3.4         
1.13.12.2       1.14.13.59      2.1.3.8         2.3.1.32        
2.3.1.-         2.6.1.36        2.6.1.71        2.6.1.105       
3.4.13.4        3.4.14.13       3.5.1.12        3.5.1.17        
3.5.1.-         3.5.2.11        3.5.-.-         4.1.1.18        
4.1.1.20        4.3.1.28        4.3.2.8         5.1.1.5         
5.1.1.9         5.4.3.2         5.4.99.58       6.1.1.6         
6.3.2.7         6.3.2.11        6.3.2.20        6.3.4.19
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00047  Lysine (Lys)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
   B05X I.V. SOLUTION ADDITIVES
    B05XB Amino acids
     B05XB03 Lysine
      D02304  Lysine (USAN/INN)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   Lysine
    D02304  Lysine (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 56-87-1
PubChem: 3349
ChEBI: 18019
ChEMBL: CHEMBL8085
KNApSAcK: C00001378
PDB-CCD: LYS[PDBj]
3DMET: B00013
NIKKAJI: J9.176F
KCF data Show

ATOM        10
            1   C1c C    29.3300  -16.8700
            2   C1b C    28.1400  -16.1700
            3   C6a C    30.5200  -16.1000
            4   N1a N    29.3300  -18.2700
            5   C1b C    26.9500  -16.8700
            6   O6a O    31.7100  -16.8000
            7   O6a O    30.5200  -14.7000
            8   C1b C    25.6900  -16.2400
            9   C1b C    24.5000  -16.9400
            10  N1a N    23.2400  -16.2400
BOND        9
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Up
            4     2   5 1
            5     3   6 1
            6     3   7 2
            7     5   8 1
            8     8   9 1
            9     9  10 1

» Japanese version

KEGG   COMPOUND: C00135Help
Entry
C00135                      Compound                               

Name
L-Histidine;
(S)-alpha-Amino-1H-imidazole-4-propionic acid
Formula
C6H9N3O2
Exact mass
155.0695
Mol weight
155.1546
Structure
Mol fileKCF fileDB search
Remark
Same as: D00032
Reaction
Pathway
map00340  Histidine metabolism
map00410  beta-Alanine metabolism
map00970  Aminoacyl-tRNA biosynthesis
map01060  Biosynthesis of plant secondary metabolites
map01065  Biosynthesis of alkaloids derived from histidine and purine
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01230  Biosynthesis of amino acids
map02010  ABC transporters
map04974  Protein digestion and absorption
map05230  Central carbon metabolism in cancer
Module
M00026  Histidine biosynthesis, PRPP => histidine
M00045  Histidine degradation, histidine => N-formiminoglutamate => glutamate
Enzyme
1.1.1.23        1.14.99.52      2.1.1.44        2.1.1.-         
2.3.1.33        2.6.1.38        3.4.13.18       3.4.13.20       
4.1.1.22        4.3.1.3         5.1.1.24        6.1.1.21        
6.3.2.11
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00135  Histidine (His)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   L-Histidine
    D00032  Histidine (USP/INN)
Pharmaceutical additives in Japan [BR:br08316]
 Stabilizing agent
  D00032  [003617] L-Histidine
 Buffering agent
  D00032  [003617] L-Histidine
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00032  L-Histidine
  D00032  L-Histidine hydrochloride hydrate
BRITE hierarchy
Other DBs
CAS: 71-00-1
PubChem: 3435
ChEBI: 15971
ChEMBL: CHEMBL17962
KNApSAcK: C00001363
PDB-CCD: HIS[PDBj]
3DMET: B01171
NIKKAJI: J4.881J
KCF data Show

ATOM        11
            1   C8x C    24.1997  -18.0246
            2   N5x N    24.6612  -19.3463
            3   C8y C    26.0609  -19.3157
            4   C8x C    26.4644  -17.9751
            5   N4x N    25.3141  -17.1771
            6   C1b C    27.2524  -20.0200
            7   C1c C    28.4649  -19.3200
            8   C6a C    29.6773  -20.0200
            9   O6a O    30.8897  -19.3200
            10  O6a O    29.6773  -21.4200
            11  N1a N    28.4649  -17.9202
BOND        11
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     1   5 1
            6     3   6 1
            7     6   7 1
            8     7   8 1
            9     8   9 1
            10    8  10 2
            11    7  11 1 #Down

» Japanese version

KEGG   COMPOUND: C00064Help
Entry
C00064                      Compound                               

Name
L-Glutamine;
L-2-Aminoglutaramic acid
Formula
C5H10N2O3
Exact mass
146.0691
Mol weight
146.1445
Structure
Mol fileKCF fileDB search
Remark
Same as: D00015
Reaction
Pathway
map00220  Arginine biosynthesis
map00230  Purine metabolism
map00240  Pyrimidine metabolism
map00250  Alanine, aspartate and glutamate metabolism
map00471  D-Glutamine and D-glutamate metabolism
map00630  Glyoxylate and dicarboxylate metabolism
map00910  Nitrogen metabolism
map00970  Aminoacyl-tRNA biosynthesis
map01060  Biosynthesis of plant secondary metabolites
map01100  Metabolic pathways
map01120  Microbial metabolism in diverse environments
map01230  Biosynthesis of amino acids
map02010  ABC transporters
map02020  Two-component system
map04724  Glutamatergic synapse
map04727  GABAergic synapse
map04964  Proximal tubule bicarbonate reclamation
map04974  Protein digestion and absorption
map04978  Mineral absorption
map05230  Central carbon metabolism in cancer
Module
M00048  Inosine monophosphate biosynthesis, PRPP + glutamine => IMP
M00051  Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP
Enzyme
1.4.1.13        1.4.1.14        1.4.7.1         2.3.1.14        
2.3.1.68        2.3.2.1         2.3.2.14        2.4.2.14        
2.6.1.15        2.6.1.16        2.6.1.50        2.6.1.64        
2.6.1.85        2.6.1.86        2.6.1.100       2.6.1.101       
2.7.3.13        3.5.1.2         3.5.1.38        4.1.3.27        
4.3.2.10        4.3.3.6         5.1.1.10        6.1.1.18        
6.3.1.2         6.3.4.2         6.3.5.1         6.3.5.2         
6.3.5.3         6.3.5.4         6.3.5.5         6.3.5.6         
6.3.5.7         6.3.5.9         6.3.5.10        6.3.5.11        
6.3.5.12        6.3.5.13        6.3.5.-
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00064  Glutamine (Gln)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
   A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
    A16AA Amino acids and derivatives
     A16AA03 Glutamine
      D00015  Glutamine (USP) <JP/US>
USP drug classification [BR:br08302]
 Gastrointestinal Agents
  Gastrointestinal Agents, Other
   Glutamine
    D00015  Glutamine (USP)
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  23  Digestive organ agents
   232  Peptic ulcer agents
    2322  Glutamines
     D00015  Glutamine (USP); L-Glutamine (JP17)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   L-Glutamine
    D00015  Glutamine (USP)
Pharmaceutical additives in Japan [BR:br08316]
 Diluting agent
  D00015  [003612] L-Glutamine
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00015  L-Glutamine
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D00015
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D00015
BRITE hierarchy
Other DBs
CAS: 56-85-9
PubChem: 3364
ChEBI: 18050
ChEMBL: CHEMBL930
KNApSAcK: C00001359
PDB-CCD: GLN[PDBj]
3DMET: B00017
NIKKAJI: J9.170G
KCF data Show

ATOM        10
            1   C1c C    23.8378  -17.4606
            2   C1b C    25.0254  -16.7178
            3   C6a C    22.6035  -16.7995
            4   N1a N    23.8787  -18.8587
            5   C1b C    26.2597  -17.3787
            6   O6a O    21.4451  -17.5952
            7   O6a O    22.6209  -15.4015
            8   C5a C    27.4472  -16.6416
            9   N1a N    28.6814  -17.3027
            10  O5a O    27.4704  -15.2435
BOND        9
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     3   6 1
            6     3   7 2
            7     5   8 1
            8     8   9 1
            9     8  10 2

» Japanese version

DBGET integrated database retrieval system